Search
This editorial by Wayne Winegarden, Ph.D. appeared in Forbes on April 27, 2017. Dr. Winegarden is the Managing Editor for EconoSTATS and a senior Fellow in Business and Economics at the Pacific Research Institute.
Read More
his editorial by Leona Aglukkaq appeared in the Washington Post on May 12, 2017. Leona Aglukkaq was a member of Canadian House of Commons representing the riding of Nunavut until 2015. She previously served as Canada’s minister of health from 2008-2013.
Read MoreEllen L. Carmichael’s editorial appeared in The Hayride on May 5, 2017. Carmichael formerly served as press secretary to now-Health and Human Services Secretary Tom Price, M.D. She is currently president of The Lafayette Company.
Read MoreIntroduction This supplement to the American Journal of Tropical Medicine and Hygiene, entitled “The pandemic of falsified medicines: laboratory and field innovations and policy perspectives,” showcases 17 articles on detection technologies and methods, field surveillance data, multisectorial perspectives, and policy interventions and recommendations needed to create a coordinated and effective response to curb the pandemic of poor-quality medicines. The goal…
Read MoreAli Schroer wrote this editorial for the Washington Examiner on May 10, 2017.
Like millions of Americans, I take allergy medicine. A few years ago, my doctor urged me to bid farewell to my local pharmacy and instead buy my medication from an online Canadian drug store, where it was cheaper. What terrible advice! The website was counterfeit and sent me “medicine” that was anything but — causing me to get severely sick . . .
Read More
In an editorial published in the Philadelphia Inquirer, Louis J. Freeh, former director of the FBI and former federal judge, warns that allowing American citizens to purchase medicine from foreign countries puts them at risk from counterfeit drugs, would incentive criminal organizations to make counterfeit drugs, and places more stress on law enforcement efforts to combat the issue.
Read MoreGeorge Karavetsos, former head of the U.S. Food and Drug Administration’s Office of Criminal Investigations wrote this editorial for the Miami Herald on May 6, 2017.
Read MoreOn May 9th, the board of the Partnership for Safe Medicines sent the following letter to all members of the U.S. Senate. Dear Senator, The Partnership for Safe Medicines has dutifully studied the problem of counterfeit drugs in America for over a decade. We have examined court transcripts of prosecutions of counterfeiters, watched scientists test counterfeits in their labs that looked…
Read More
A Greensboro, North Carolina news station, WFMY News2, is warning viewers that the Internet is filled with fake online pharmacies that sell counterfeit drugs. In the television segment accompanying the story, WFMY shared surveillance images of a suspected drop-shipper posting up to 80 packages of counterfeit medications a day. The U.S. Postal Inspector WFMY spoke to described the state of…
Read More
Narinder Kaulder, head of Operations for River East, a company named in the Canada Drugs indictment, is currently fighting extradition from England on charges he was part of the conspiracy that sold counterfeit cancer medication to U.S. oncology clinics in 2012, the Daily Mail reports. According to the CanadaDrugs Indictment, lot number B6011 of Avastin that was shipped by River East…
Read More